Advertisement

Reactions Weekly

, Volume 1739, Issue 1, pp 80–80 | Cite as

Capecitabine

Coronary vasospasm: case report
Case report
  • 13 Downloads

Reference

  1. Chakrabarti S, et al. Safety and tolerability of the bolus 5- fluorouracil (5-FU) based FLOX and IFL regimens in patients who developed fluoropyrimidine-induced coronary vasospasm during therapy with infusional 5- FU or capecitabine. Journal of Clinical Oncology 36 (Suppl. 1): No. 15, May 2018. Available from: URL: http://doi.org/10.1200/JCO.2018.36.15_suppl.e15513 [abstract] -USA

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations